Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
复制标题
DOI:
10.1161/circresaha.110.234369
复制
发表时间:
2011-01-21
影响因子:
20.1
通讯作者:
Duan DD
中科院分区:
文献类型:
--
作者:
He X;Gao X;Peng L;Wang S;Zhu Y;Ma H;Lin J;Duan DD
Tachycardia-induced atrial fibrosis is a hallmark of structural remodeling of atrial fibrillation (AF). The molecular mechanisms underlying the AF-induced atrial fibrosis remain unclear. To determine the role of angiotensin II (AngII)/AT1 receptor-coupled transforming growth factor β1 (TGF-β1)/Smads signaling pathway in the AF-induced atrial fibrosis. Rapid atrial pacing (RAP, 1000 ppm) was applied to the left atrium of rabbit heart to induce atrial fibrillation and fibrosis. Quantitative PCR and Western blot analysis revealed that RAP caused a marked increase in the expression of AngII, TGF-β1, phosphorylated Smad2/3 (P-Smad2/3), Arkadia, and hydroxyproline synthesis. But the expression of Smad7, a key endogenous antagonist of the TGF-β1/Smads-mediated fibrosis, was significantly decreased. These changes were dose-dependently reversed by AT1 receptor antagonist losartan, implicating the involvement of AF-induced release of AngII and activation of AT1-receptor specific pathway. In the adult rabbit cardiac fibroblasts, AngII increased the expression of TGF-β1, P-Smad2/3, Smad4, Arkadia, and collagen I synthesis and significantly reduced Smad7 expression. These effects of AngII were reversed by losartan, but not by the AT2 antagonist (PD123319). In addition, extracellular signal-regulated kinase (ERK) inhibitor and anti-TGF-β1 antibody also blocked the AngII-induced downregulation of Smad7. Silencing of Smad7 gene by siRNA abolished losartan's antagonism on AngII's fibrogenic effects in cardiac fibroblasts while overexpression of Smad7 blocked AngII-induced increase in collagen I synthesis. AngII/AT1-receptor specific activation of Arkadia-mediated poly-ubiquitination and degradation of Smad7 may decrease the inhibitory feedback regulation of TGF-β1/Smads signaling and serves as a key mechanism for AF-induced atrial fibrosis.